|
Arnsten, Amy F T; Pliszka, Steven R (2011) Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav 99:211-6
|
|
Arnsten, Amy F T (2011) Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry 69:e89-99
|
|
Arnsten, Amy F T (2011) Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci 29:215-23
|
|
Arnsten, Amy F T; Paspalas, Constantinos D; Gamo, Nao J et al. (2010) Dynamic Network Connectivity: A new form of neuroplasticity. Trends Cogn Sci 14:365-75
|
|
Salloway, S; Sperling, R; Gilman, S et al. (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73:2061-70
|
|
Arnsten, Amy F T (2009) Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci 10:410-22
|
|
Robbins, T W; Arnsten, A F T (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-87
|
|
Ramos, Brian P; Stark, David; Verduzco, Luis et al. (2006) Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals. Learn Mem 13:770-6
|
|
Arnsten, Amy F T; Ramos, Brian P; Birnbaum, Shari G et al. (2005) Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11:121-8
|
|
Birnbaum, S G; Yuan, P X; Wang, M et al. (2004) Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306:882-4
|
Showing the most recent 10 out of 36 publications
